Loading stock data…
OFIX
$11.91+0.15 (+1.28%)
Market ClosedLast close May 1
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Orthofix Medical Inc. in the Healthcare sector is trading at $11.91. The stock is currently 30% below its 52-week high of $16.99, remaining 13.9% below its 200-day moving average. Technical signals show neutral RSI of 38 and bearish MACD signal, explaining why OFIX maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 38) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$11.91
Potential Upside
5%
Whystock Fair Value$12.51
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global L...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$482.33M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.82
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-27.49%
Volume
Today's trading volume
194,208
Recent News
How The Orthofix Medical (OFIX) Story Is Shifting After Q4 Models And 2026 Guidance
Orthofix Medical is in the spotlight as Street price targets reset from earlier levels in the low to mid US$20s into a tighter US$17 to US$20 range, while a model fair value of US$17.25 remains unchanged. These revisions are tied to refreshed Q4 inputs, updated 2026 guidance, and a longer timeline to the company’s adjusted EBITDA margin goals, which are shaping both bullish and cautious views. Read on to see how to track this evolving narrative and what the latest assumptions may mean for...
Down 12.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Orthofix (OFIX)
Orthofix (OFIX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Orthofix Medical (OFIX) Narrative Shifts As Analysts Recut Targets And Profitability Timelines
Orthofix Medical has seen its modeled fair value price target trimmed from $19.25 to $17.25 per share, a move that places more attention on how analysts are recalibrating expectations. Recent commentary links these reduced targets to Q4 results, updated long term guidance, and a mix of constructive and cautious views on the company’s execution and growth path. As you read on, you will see how these shifting targets fit into the broader Orthofix story and what to watch as the narrative...
Orthofix Medical Inc. (OFIX) Target Reduced at Canaccord Following Q4 Results and 2026 Outlook Update
Orthofix Medical Inc. (NASDAQ:OFIX) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. Orthofix Medical Inc. (NASDAQ:OFIX) is given the tenth position on our list of small-cap stocks. TheFly reported on February 26 that Canaccord reduced its price target for OFIX from $24 to $20 and gave it a Buy rating. […]
How The Orthofix Medical (OFIX) Narrative Is Shifting With Margin Delays And New 2026 Guidance
The latest research on Orthofix Medical comes with a lower fair value estimate, shifting from US$22.55 to US$19.25, roughly a 14.6% cut to the price target that anchors much of the current debate. Some analysts still see room for long term earnings power, while others focus on execution risk and the extended margin timeline, which helps explain why ratings and targets are not aligned. As you read on, you will see how these moving pieces shape the evolving Orthofix Medical story and what to...